Clal Biotechnology Industries Ltd.
CBI.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.33M
Close$
Share Statistics
| Market cap | $37.33 Million |
|---|---|
| Enterprise Value | $52.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | 0.36 |
| Outstanding Shares | 147,250,000 |
Return
| Return on Equity | -69.31% |
|---|---|
| Return on Assets | -27.17% |
| Return on Invested Capital | -17.45% |
Valuation & Multiples
| P/E Ratio | -4.1 |
|---|---|
| PEG | 9.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 40.72 |
| Enterprise Value to EBIT | -19.22 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 1.27 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Clal Biotechnology Industries Ltd.
121 employees
CEO: Avraham Matityahu Fischer Clal Biotechnology Industries Ltd. (CBI) operates as a venture capital and private equity firm, primarily funding innovative companies within the life sciences, medical device, biopharmaceutical, and broader biotechnology sectors. The fi...